DUSA Pharmaceuticals, Inc. (DUSA) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $56.57 -0.14%
Financial Fact:
General and administrative: 2.91M
Today's EPS Names:
EACO, ITGR, CARE, More
Financial Fact:
General and administrative: 2.91M
Today's EPS Names:
EACO, ITGR, CARE, More
Join SI Premium – FREE
DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $13.84 million.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Exlservice (EXLS) PT Raised to $48 at Stifel
- Wintrust Financial shares gain 2.5% as UBS lifts rating on strong outlook
- GATX Corp. (GATX) Tops Q3 EPS by 46c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
